top of page
  • LinkedIn

Ramkumar Mandalam, PhD

Cell Therapy Product Development and Commercialization Expert

Career Highlights

  • Strategic and results-oriented biotechnology CEO with proven track record of leadership and execution

  • Over twenty-five years of executive and scientific experience building teams, raising capital and advancing programs from research through product development towards commercialization

  • As CEO of Cellerant Therapeutics, Dr. Mandalam led the development of a pipeline of candidates for the treatment of hematological malignancies rapidly advancing the lead program to late clinical stage, established a regulatory strategy for product approval and obtained RMAT designation for the lead program 

  • As executive director of product development at Geron Corporation, managed the development and manufacturing of off-the-shelf pluripotent stem cell-based therapies for the treatment of degenerative diseases and cancer

  • Held various positions in Research and Development at Aastrom Biosciences

  • Serves on the Boards of Cryoport, Inc and Stempeutics Research Pvt. Ltd. 

  • Author/co-author of several publications, patent applications and abstracts


  • PhD, Chemical Engineering: University of Michigan

bottom of page